Literature DB >> 4053426

Immunological and microbiological factors in the pathogenesis of atherosclerosis.

M F Lopes-Virella, G Virella.   

Abstract

Among the several pathological events that lead to the formation of an atheromatous lesion, endothelial cell damage, smooth muscle cell proliferation, and foam cell formation, are considered as particularly significant. In this review we summarize data suggesting that immunological and microbial factors may cause, directly or indirectly, these pathological events. Binding of immunocomplexes to endothelial cells, phagocytic cells, platelets, or erythrocytes could be the starting point for a variety of circuits leading to endothelial cell cytotoxicity and to the release of a variety of mediators, including cell proliferative factors. Endothelial cell toxicity could also be induced, directly or indirectly, by endotoxin; however, the possibility that endotoxin and other microbial factors may induce abnormalities in lipid metabolism at the monocyte/macrophage level which eventually result in intracellular accumulation of cholesterol (particularly if cholesterol levels are elevated) is specially attractive as a potential pathogenic mechanism. The various pathologic pathways discussed in this review appear plausible on the basis of our current knowledge and point to the need to investigate the potential role of infectious processes, autoimmune reactions, and administration of antigenic compounds as possible risk factors for the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053426     DOI: 10.1016/0090-1229(85)90107-2

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  12 in total

1.  Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

Authors:  S Nityanand; L Truedsson; A Mustafa; C Bergmark; A K Lefvert
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR.

Authors:  B Farsak; A Yildirir; Y Akyön; A Pinar; M Oç; E Böke; S Kes; L Tokgözoğlu
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Epidemiologic Analysis of Diverticulitis.

Authors:  Marie D Jena; Peter W Marcello; Patricia L Roberts; Thomas E Read; David J Schoetz; Jason F Hall; Todd Francone; Rocco Ricciardi
Journal:  Clin Colon Rectal Surg       Date:  2016-09

4.  De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.

Authors:  I W Fong; B Chiu; E Viira; D Jang; J B Mahony
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 5.  Role of protein glycosylation in immune regulation.

Authors:  E F Hounsell; M J Davies
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

6.  Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice.

Authors:  E Blessing; T M Lin; L A Campbell; M E Rosenfeld; D Lloyd; C Kuo
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Dental disease and risk of coronary heart disease and mortality.

Authors:  F DeStefano; R F Anda; H S Kahn; D F Williamson; C M Russell
Journal:  BMJ       Date:  1993-03-13

8.  Current treatment and future prospects for the management of acute coronary syndromes: consensus recommendations of the 1997 ushuaia conference, tierra del fuego, Argentina.

Authors:  E Gurfinkel
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 9.  Chlamydial infections of the heart.

Authors:  M Odeh; A Oliven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

10.  Molecules mediating adhesion of T and B cells, monocytes and granulocytes to vascular endothelial cells.

Authors:  J Prieto; P G Beatty; E A Clark; M Patarroyo
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.